Dipòsit Digital de Documents de la UAB
Publicación
Artículo científico (JournalArticle)
Structural neuroimaging biomarkers for obsessive-compulsive disorder in the ENIGMA-OCD consortium, medication matters
No diagnostic biomarkers are available for obsessive-compulsive disorder (OCD). Here, we aimed to identify magnetic resonance imaging (MRI) biomarkers for OCD, using 46 data sets with 2304 OCD patients and 2068 healthy controls from the ENIGMA consortium. We performed machine learning analysis of regional measures of cortical thickness, surface area and subcortical volume and tested classification performance using cross-validation. Classification performance for OCD vs. controls using the complete sample with different classifiers and cross-validation strategies was poor. When models were validated on data from other sites, model performance did not exceed chance-level. In contrast, fair classification performance was achieved when patients were grouped according to their medication status. These results indicate that medication use is associated with substantial differences in brain anatomy that are widely distributed, and indicate that clinical heterogeneity contributes to the poor performance of structural MRI as a disease marker.
Proyecto:
Agència de Gestió d'Ajuts Universitaris i de Recerca 2017/SGR-1247
,
Instituto de Salud Carlos III PI040829
,
Instituto de Salud Carlos III FI17/00294
,
Ministerio de Economía y Competitividad CPII16/00048
,
Ministerio de Economía y Competitividad PI13/01958
,
Ministerio de Economía y Competitividad PI16/00889
,
Ministerio de Economía y Competitividad PI14/00419
,
Fundació la Marató de TV3 01/2010
,
Fundació la Marató de TV3 091710